Image via HRM Asia
Last updated
Thermo Fisher Scientific: Geographic Expansion
Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Source: HRM Asia
The leadership read
Market entry of this kind typically deepens demand for biotech & pharma leadership bench strength in the region over the following 12–18 months.
Market context: This lands while the Talent Market Index reads 111.1 (Hot) — up 5.2 versus the prior month — and Asia signal share is rising (+3.7pts).
Thermo Fisher Scientific: 2 signals in the last 90 days — above the Biotech & Pharma median of 1 across 24 tracked companies; 0.2% of MitchelLake's Asia signal flow; 3 tracked across 56 days.
Market entry — the MitchelLake playbook
When a company expands into a new market, the first leadership hires decide whether it lands. A selection of market entries we've run:
Market entry · Oceania
Square
Executive Search Fintech
Market entry
Dropbox
Executive Search for SaaS
Market entry · Asia
Deliveroo
Executive Search in ASEAN
Market entry · Oceania
SurveyMonkey
Managing Director APAC (first hire in region) / Country Manager
Market entry · Asia
LivePerson
Director ASEAN (first hire in region); also Head of Presales APAC
Market entry · Oceania
Etsy
Managing Director, Australia + Asia (MD APAC)
MitchelLake in this thematic
Also at Thermo Fisher Scientific →
More signals across Biotech & Pharma
Geographic Expansion · Asia
Promomed Group →Promomed Group (Russian pharmaceutical company) is expanding into Vietnam's pharmaceutical market with strategic partnerships. Founder Petr Bely met with Vietnam's Minister of Health to discuss long-term cooperation, technology transfer, and manufacturing operations targeting innovative drugs, biosimilars, and monoclonal antibodies
Restructuring · Asia
Samsung Biologics →Samsung Biologics unionized workers voted to leave the Samsung Group United Union and form an independent labor union, following months of work-to-rule campaigns and strikes over pay and working conditions.
Capital Raising · Asia
Legend Biotech →First Beijing Investment Ltd acquired $43.78 million stake (2.3M shares) in Legend Biotech, a cancer cell therapy developer
Partnership · Asia
Bristol Myers Squibb →Bristol Myers Squibb partners with China's Hengrui Pharma on a $15.2 billion deal to advance more than a dozen early-stage drugs
Ma Activity · Asia
Gilead Sciences →Gilead Sciences agreed to acquire Ouro Medicines for up to $2.18 billion, gaining rights to antibody drug licensed from China's Keymed Biosciences
Geographic Expansion · Americas
Novartis AG →Novartis is expanding its U.S. manufacturing footprint by establishing a new site in Texas
Intelligence powered by Autonodal ↗